tirzepatide bimagrumab Eli Lilly halts trial testing experimental muscle-preserving drug with Zepbound Bimagrumab + Tirzepatide for Obesity
Description
This physiological effect has historically raised concerns about pulmonary aspiration a serious complication where stomach contents enter the lungs during intubation or while under anesthesia
The FDA found that the shortage of tirzepatide (Mounjaro and Zepbound) ended in December
Sleep disruption A smaller but notable percentage of users experience insomnia on tirzepatide
GLP-1 receptor agonists and the risk of thyroid cancer
This means patients are essentially receiving the same medication, but the prescribing approach and monitoring may differ based on the intended use
The population pharmacokinetic analysis published by Schneck et al
